APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cell Line Development CDMO

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Cell Line Development CDMO Industry Growth and Trends Forecast to 2032

5 June 2026121 pages

Choose your research edition.

Industry ResearchCell Line Development CDMO Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Cell Line Development CDMO Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Cell Line Development CDMO Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cell Line Development CDMO Market Outlook and Growth Opportunities 2026212 pages · $4,250 USDMarket Analysis & ForecastGlobal Cell Line Development CDMO Market Analysis and Forecast 2026-2032185 pages · $4,950 USD

Market perspective

According to APO Research, the global Cell Line Development CDMO market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Cell Line Development CDMO is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Cell Line Development CDMO is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cell Line Development CDMO is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Cell Line Development CDMO market include Lonza, Samsung Biologics, AGC Biologics, ProBio CDMO, Creative Biolabs, ProBioGen, InvivoGen, Eurofins Discovery and Innoprot, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Cell Line Development CDMO market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Cell Line Development CDMO market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Cell Line Development CDMO market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Cell Line Development CDMO.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Cell Line Development CDMO market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Cell Line Development CDMO Market by Company

Lonza

Samsung Biologics

AGC Biologics

ProBio CDMO

Creative Biolabs

ProBioGen

InvivoGen

Eurofins Discovery

Innoprot

AcceGen

WuXi Biologics

GenScript

Pharmaron

Bio-Inno

Dingkang Biotech

FUJIFILM

JCR Pharmaceuticals

Sartorius

Oxford BioMedica

Cobra Biologics

Evotec

Catalent

Thermo Fisher Scientific

Cytiva

Charles River Laboratories

Abzena

Shilpa Biologicals

Teijin

Cell Line Development CDMO Segment by Type

CHO Cell Line

HEK293 Cell Line

Others

Cell Line Development CDMO Segment by Application

Monoclonal Antibodies

Bispecific/Multispecific Antibodies

Recombinant Proteins/Enzymes

Gene Therapy Vectors

Viral Vaccines

Others

Cell Line Development CDMO Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cell Line Development CDMO market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cell Line Development CDMO and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cell Line Development CDMO.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Cell Line Development CDMO companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Cell Line Development CDMO Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Cell Line Development CDMO Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Cell Line Development CDMO Market Share by Region (2021-2026) Table 4. Global Cell Line Development CDMO Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Cell Line Development CDMO Market Share by Region (2027-2032) Table 6. Global Cell Line Development CDMO Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Cell Line Development CDMO Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Cell Line Development CDMO Market Size Share by Type (2021-2026) Table 9. Global Cell Line Development CDMO Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Cell Line Development CDMO Market Size Share Forecasted by Type (2027-2032) Table 11. North America Cell Line Development CDMO Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Cell Line Development CDMO Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Cell Line Development CDMO Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Cell Line Development CDMO Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Cell Line Development CDMO Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Cell Line Development CDMO Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Cell Line Development CDMO Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Cell Line Development CDMO Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Cell Line Development CDMO Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Cell Line Development CDMO Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Cell Line Development CDMO Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Cell Line Development CDMO Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Cell Line Development CDMO Market Size Share by Application (2021-2026) Table 24. Global Cell Line Development CDMO Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Cell Line Development CDMO Market Size Share Forecasted by Application (2027-2032) Table 26. North America Cell Line Development CDMO Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Cell Line Development CDMO Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Cell Line Development CDMO Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Cell Line Development CDMO Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Cell Line Development CDMO Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Cell Line Development CDMO Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Cell Line Development CDMO Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Cell Line Development CDMO Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Cell Line Development CDMO Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Cell Line Development CDMO Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Cell Line Development CDMO Industry Trends Table 37. Cell Line Development CDMO Industry Drivers Table 38. Cell Line Development CDMO Industry Opportunities and Challenges Table 39. Cell Line Development CDMO Industry Restraints Table 40. Global Cell Line Development CDMO Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Cell Line Development CDMO Revenue Market Share by Company (2021-2026) Table 42. Global Cell Line Development CDMO Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Cell Line Development CDMO Key Company Headquarters & Area Served Table 44. Global Cell Line Development CDMO Company, Product Type & Application Table 45. Global Cell Line Development CDMO Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Cell Line Development CDMO by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Lonza Company Information Table 49. Lonza Business Overview Table 50. Lonza Cell Line Development CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Lonza Cell Line Development CDMO Product Portfolio Table 52. Lonza Recent Development Table 53. Samsung Biologics Company Information Table 54. Samsung Biologics Business Overview Table 55. Samsung Biologics Cell Line Development CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Samsung Biologics Cell Line Development CDMO Product Portfolio Table 57. Samsung Biologics Recent Development Table 58. AGC Biologics Company Information Table 59. AGC Biologics Business Overview Table 60. AGC Biologics Cell Line Development CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. AGC Biologics Cell Line Development CDMO Product Portfolio Table 62. AGC Biologics Recent Development Table 63. ProBio CDMO Company Information Table 64. ProBio CDMO Business Overview Table 65. ProBio CDMO Cell Line Development CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. ProBio CDMO Cell Line Development CDMO Product Portfolio Table 67. ProBio CDMO Recent Development Table 68. Creative Biolabs Company Information Table 69. Creative Biolabs Business Overview Table 70. Creative Biolabs Cell Line Development CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Creative Biolabs Cell Line Development CDMO Product Portfolio Table 72. Creative Biolabs Recent Development Table 73. ProBioGen Company Information Table 74. ProBioGen Business Overview Table 75. ProBioGen Cell Line Development CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. ProBioGen Cell Line Development CDMO Product Portfolio Table 77. ProBioGen Recent Development Table 78. InvivoGen Company Information Table 79. InvivoGen Business Overview Table 80. InvivoGen Cell Line Development CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. InvivoGen Cell Line Development CDMO Product Portfolio Table 82. InvivoGen Recent Development Table 83. Eurofins Discovery Company Information Table 84. Eurofins Discovery Business Overview Table 85. Eurofins Discovery Cell Line Development CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Eurofins Discovery Cell Line Development CDMO Product Portfolio Table 87. Eurofins Discovery Recent Development Table 88. Innoprot Company Information Table 89. Innoprot Business Overview Table 90. Innoprot Cell Line Development CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Innoprot Cell Line Development CDMO Product Portfolio Table 92. Innoprot Recent Development Table 93. AcceGen Company Information Table 94. AcceGen Business Overview Table 95. AcceGen Cell Line Development CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. AcceGen Cell Line Development CDMO Product Portfolio Table 97. AcceGen Recent Development Table 98. WuXi Biologics Company Information Table 99. WuXi Biologics Business Overview Table 100. WuXi Biologics Cell Line Development CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. WuXi Biologics Cell Line Development CDMO Product Portfolio Table 102. WuXi Biologics Recent Development Table 103. GenScript Company Information Table 104. GenScript Business Overview Table 105. GenScript Cell Line Development CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. GenScript Cell Line Development CDMO Product Portfolio Table 107. GenScript Recent Development Table 108. Pharmaron Company Information Table 109. Pharmaron Business Overview Table 110. Pharmaron Cell Line Development CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Pharmaron Cell Line Development CDMO Product Portfolio Table 112. Pharmaron Recent Development Table 113. Bio-Inno Company Information Table 114. Bio-Inno Business Overview Table 115. Bio-Inno Cell Line Development CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Bio-Inno Cell Line Development CDMO Product Portfolio Table 117. Bio-Inno Recent Development Table 118. Dingkang Biotech Company Information Table 119. Dingkang Biotech Business Overview Table 120. Dingkang Biotech Cell Line Development CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Dingkang Biotech Cell Line Development CDMO Product Portfolio Table 122. Dingkang Biotech Recent Development Table 123. FUJIFILM Company Information Table 124. FUJIFILM Business Overview Table 125. FUJIFILM Cell Line Development CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. FUJIFILM Cell Line Development CDMO Product Portfolio Table 127. FUJIFILM Recent Development Table 128. JCR Pharmaceuticals Company Information Table 129. JCR Pharmaceuticals Business Overview Table 130. JCR Pharmaceuticals Cell Line Development CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. JCR Pharmaceuticals Cell Line Development CDMO Product Portfolio Table 132. JCR Pharmaceuticals Recent Development Table 133. Sartorius Company Information Table 134. Sartorius Business Overview Table 135. Sartorius Cell Line Development CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Sartorius Cell Line Development CDMO Product Portfolio Table 137. Sartorius Recent Development Table 138. Oxford BioMedica Company Information Table 139. Oxford BioMedica Business Overview Table 140. Oxford BioMedica Cell Line Development CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. Oxford BioMedica Cell Line Development CDMO Product Portfolio Table 142. Oxford BioMedica Recent Development Table 143. Cobra Biologics Company Information Table 144. Cobra Biologics Business Overview Table 145. Cobra Biologics Cell Line Development CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 146. Cobra Biologics Cell Line Development CDMO Product Portfolio Table 147. Cobra Biologics Recent Development Table 148. Evotec Company Information Table 149. Evotec Business Overview Table 150. Evotec Cell Line Development CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 151. Evotec Cell Line Development CDMO Product Portfolio Table 152. Evotec Recent Development Table 153. Catalent Company Information Table 154. Catalent Business Overview Table 155. Catalent Cell Line Development CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 156. Catalent Cell Line Development CDMO Product Portfolio Table 157. Catalent Recent Development Table 158. Thermo Fisher Scientific Company Information Table 159. Thermo Fisher Scientific Business Overview Table 160. Thermo Fisher Scientific Cell Line Development CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 161. Thermo Fisher Scientific Cell Line Development CDMO Product Portfolio Table 162. Thermo Fisher Scientific Recent Development Table 163. Cytiva Company Information Table 164. Cytiva Business Overview Table 165. Cytiva Cell Line Development CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 166. Cytiva Cell Line Development CDMO Product Portfolio Table 167. Cytiva Recent Development Table 168. Charles River Laboratories Company Information Table 169. Charles River Laboratories Business Overview Table 170. Charles River Laboratories Cell Line Development CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 171. Charles River Laboratories Cell Line Development CDMO Product Portfolio Table 172. Charles River Laboratories Recent Development Table 173. Abzena Company Information Table 174. Abzena Business Overview Table 175. Abzena Cell Line Development CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 176. Abzena Cell Line Development CDMO Product Portfolio Table 177. Abzena Recent Development Table 178. Shilpa Biologicals Company Information Table 179. Shilpa Biologicals Business Overview Table 180. Shilpa Biologicals Cell Line Development CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 181. Shilpa Biologicals Cell Line Development CDMO Product Portfolio Table 182. Shilpa Biologicals Recent Development Table 183. Teijin Company Information Table 184. Teijin Business Overview Table 185. Teijin Cell Line Development CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 186. Teijin Cell Line Development CDMO Product Portfolio Table 187. Teijin Recent Development Table 188. North America Cell Line Development CDMO Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 189. North America Cell Line Development CDMO Market Size by Country (2021-2026) & (US$ Million) Table 190. North America Cell Line Development CDMO Market Share by Country (2021-2026) Table 191. North America Cell Line Development CDMO Market Size Forecast by Country (2027-2032) & (US$ Million) Table 192. North America Cell Line Development CDMO Market Share Forecast by Country (2027-2032) Table 193. Europe Cell Line Development CDMO Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 194. Europe Cell Line Development CDMO Market Size by Country (2021-2026) & (US$ Million) Table 195. Europe Cell Line Development CDMO Market Share by Country (2021-2026) Table 196. Europe Cell Line Development CDMO Market Size Forecast by Country (2027-2032) & (US$ Million) Table 197. Europe Cell Line Development CDMO Market Share Forecast by Country (2027-2032) Table 198. Asia-Pacific Cell Line Development CDMO Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 199. Asia-Pacific Cell Line Development CDMO Market Size by Country (2021-2026) & (US$ Million) Table 200. Asia-Pacific Cell Line Development CDMO Market Share by Country (2021-2026) Table 201. Asia-Pacific Cell Line Development CDMO Market Size Forecast by Country (2027-2032) & (US$ Million) Table 202. Asia-Pacific Cell Line Development CDMO Market Share Forecast by Country (2027-2032) Table 203. Latin America Cell Line Development CDMO Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 204. Latin America Cell Line Development CDMO Market Size by Country (2021-2026) & (US$ Million) Table 205. Latin America Cell Line Development CDMO Market Share by Country (2021-2026) Table 206. Latin America Cell Line Development CDMO Market Size Forecast by Country (2027-2032) & (US$ Million) Table 207. Latin America Cell Line Development CDMO Market Share Forecast by Country (2027-2032) Table 208. Middle East & Africa Cell Line Development CDMO Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 209. Middle East & Africa Cell Line Development CDMO Market Size by Country (2021-2026) & (US$ Million) Table 210. Middle East & Africa Cell Line Development CDMO Market Share by Country (2021-2026) Table 211. Middle East & Africa Cell Line Development CDMO Market Size Forecast by Country (2027-2032) & (US$ Million) Table 212. Middle East & Africa Cell Line Development CDMO Market Share Forecast by Country (2027-2032) Table 213. Research Programs/Design for This Report Table 214. Authors List of This Report Table 215. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Cell Line Development CDMO Product Image Figure 3. Global Cell Line Development CDMO Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Cell Line Development CDMO Market Size (2021-2032) & (US$ Million) Figure 5. Global Cell Line Development CDMO Market Share by Region: 2025 VS 2032 Figure 6. Global Cell Line Development CDMO Market Share by Region (2021-2032) Figure 7. North America Cell Line Development CDMO Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Cell Line Development CDMO Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Cell Line Development CDMO Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Cell Line Development CDMO Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Cell Line Development CDMO Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. CHO Cell Line Image Figure 13. Global CHO Cell Line Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. HEK293 Cell Line Image Figure 15. Global HEK293 Cell Line Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Others Image Figure 17. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Global Cell Line Development CDMO Market Size Overview by Type (2021-2032) & (US$ Million) Figure 19. Global Cell Line Development CDMO Market Share by Type 2025 VS 2032 Figure 20. North America Cell Line Development CDMO Market Size Share by Type (2021-2032) Figure 21. Europe Cell Line Development CDMO Market Size Share by Type (2021-2032) Figure 22. Asia-Pacific Cell Line Development CDMO Market Size Share by Type (2021-2032) Figure 23. Latin America Cell Line Development CDMO Market Size Share by Type (2021-2032) Figure 24. Middle East and Africa Cell Line Development CDMO Market Size Share by Type (2021-2032) Figure 25. Monoclonal Antibodies Image Figure 26. Global Monoclonal Antibodies Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Bispecific/Multispecific Antibodies Image Figure 28. Global Bispecific/Multispecific Antibodies Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Recombinant Proteins/Enzymes Image Figure 30. Global Recombinant Proteins/Enzymes Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Gene Therapy Vectors Image Figure 32. Global Gene Therapy Vectors Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Viral Vaccines Image Figure 34. Global Viral Vaccines Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Others Image Figure 36. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Global Cell Line Development CDMO Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Cell Line Development CDMO Market Share by Application 2025 VS 2032 Figure 39. North America Cell Line Development CDMO Market Size Share by Application (2021-2032) Figure 40. Europe Cell Line Development CDMO Market Size Share by Application (2021-2032) Figure 41. Asia-Pacific Cell Line Development CDMO Market Size Share by Application (2021-2032) Figure 42. Latin America Cell Line Development CDMO Market Size Share by Application (2021-2032) Figure 43. Middle East and Africa Cell Line Development CDMO Market Size Share by Application (2021-2032) Figure 44. Global Top 5 and 10 Cell Line Development CDMO Players Market Share by Revenue in 2025 Figure 45. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 46. North America Cell Line Development CDMO Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 47. North America Cell Line Development CDMO Market Share by Country: 2021 VS 2025 VS 2032 Figure 48. North America Cell Line Development CDMO Market Share by Country (2021-2032) Figure 49. Europe Cell Line Development CDMO Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Cell Line Development CDMO Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Cell Line Development CDMO Market Share by Country (2021-2032) Figure 52. Asia-Pacific Cell Line Development CDMO Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 53. Asia-Pacific Cell Line Development CDMO Market Share by Country: 2021 VS 2025 VS 2032 Figure 54. Asia-Pacific Cell Line Development CDMO Market Share by Country (2021-2032) Figure 55. Latin America Cell Line Development CDMO Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Cell Line Development CDMO Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Cell Line Development CDMO Market Share by Country (2021-2032) Figure 58. Middle East & Africa Cell Line Development CDMO Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Middle East & Africa Cell Line Development CDMO Market Share by Country: 2021 VS 2025 VS 2032 Figure 60. Middle East & Africa Cell Line Development CDMO Market Share by Country (2021-2032) Figure 61. Years Considered Figure 62. Research Process Figure 63. Key Executives Interviewed

Scope & coverage.

Types
  • CHO Cell Line
  • HEK293 Cell Line
  • Others
Applications
  • Monoclonal Antibodies
  • Bispecific/Multispecific Antibodies
  • Recombinant Proteins/Enzymes
  • Gene Therapy Vectors
  • Viral Vaccines
  • Others
Companies covered
  • Lonza
  • Samsung Biologics
  • AGC Biologics
  • ProBio CDMO
  • Creative Biolabs
  • ProBioGen
  • InvivoGen
  • Eurofins Discovery
  • Innoprot
  • AcceGen
  • WuXi Biologics
  • GenScript
  • Pharmaron
  • Bio-Inno
  • Dingkang Biotech
  • FUJIFILM
  • JCR Pharmaceuticals
  • Sartorius
  • Oxford BioMedica
  • Cobra Biologics
  • Evotec
  • Catalent
  • Thermo Fisher Scientific
  • Cytiva
  • Charles River Laboratories
  • Abzena
  • Shilpa Biologicals
  • Teijin

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Cell Line Development CDMO Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Cell Line Development CDMO Market Size by Region (2021-2032)
  5. 1.4.1 Global Cell Line Development CDMO Market Size by Region (2021-2026)
  6. 1.4.2 Global Cell Line Development CDMO Market Size by Region (2027-2032)
  7. 1.5 Key Regions Cell Line Development CDMO Market Size (2021-2032)
  8. 1.5.1 North America Cell Line Development CDMO Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Cell Line Development CDMO Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Cell Line Development CDMO Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Cell Line Development CDMO Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Cell Line Development CDMO Market Size Growth Rate (2021-2032)
2 Cell Line Development CDMO Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 CHO Cell Line
  3. 2.1.2 HEK293 Cell Line
  4. 2.1.3 Others
  5. 2.2 Global Cell Line Development CDMO Market Size by Type
  6. 2.2.1 Global Cell Line Development CDMO Market Size Overview by Type (2021-2032)
  7. 2.2.2 Global Cell Line Development CDMO Historic Market Size Review by Type (2021-2026)
  8. 2.2.3 Global Cell Line Development CDMO Market Size Forecasted by Type (2027-2032)
  9. 2.3 Global Cell Line Development CDMO Market Size by Regions
  10. 2.3.1 North America Cell Line Development CDMO Market Size Breakdown by Type (2021-2026)
  11. 2.3.2 Europe Cell Line Development CDMO Market Size Breakdown by Type (2021-2026)
  12. 2.3.3 Asia-Pacific Cell Line Development CDMO Market Size Breakdown by Type (2021-2026)
  13. 2.3.4 South America Cell Line Development CDMO Market Size Breakdown by Type (2021-2026)
  14. 2.3.5 Middle East and Africa Cell Line Development CDMO Market Size Breakdown by Type (2021-2026)
3 Cell Line Development CDMO Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Monoclonal Antibodies
  3. 3.1.2 Bispecific/Multispecific Antibodies
  4. 3.1.3 Recombinant Proteins/Enzymes
  5. 3.1.4 Gene Therapy Vectors
  6. 3.1.5 Viral Vaccines
  7. 3.1.6 Others
  8. 3.2 Global Cell Line Development CDMO Market Size by Application
  9. 3.2.1 Global Cell Line Development CDMO Market Size Overview by Application (2021-2032)
  10. 3.2.2 Global Cell Line Development CDMO Historic Market Size Review by Application (2021-2026)
  11. 3.2.3 Global Cell Line Development CDMO Market Size Forecasted by Application (2027-2032)
  12. 3.3 Global Cell Line Development CDMO Market Size by Regions
  13. 3.3.1 North America Cell Line Development CDMO Market Size Breakdown by Application (2021-2026)
  14. 3.3.2 Europe Cell Line Development CDMO Market Size Breakdown by Application (2021-2026)
  15. 3.3.3 Asia-Pacific Cell Line Development CDMO Market Size Breakdown by Application (2021-2026)
  16. 3.3.4 South America Cell Line Development CDMO Market Size Breakdown by Application (2021-2026)
  17. 3.3.5 Middle East and Africa Cell Line Development CDMO Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Cell Line Development CDMO Industry Trends
  2. 4.2 Cell Line Development CDMO Industry Drivers
  3. 4.3 Cell Line Development CDMO Industry Opportunities and Challenges
  4. 4.4 Cell Line Development CDMO Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Cell Line Development CDMO Revenue (2021-2026)
  2. 5.2 Global Cell Line Development CDMO Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Cell Line Development CDMO Key Company Headquarters & Area Served
  4. 5.4 Global Cell Line Development CDMO Company, Product Type & Application
  5. 5.5 Global Cell Line Development CDMO Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Cell Line Development CDMO Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Cell Line Development CDMO Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Cell Line Development CDMO Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Lonza
  2. 6.1.1 Lonza Company Information
  3. 6.1.2 Lonza Business Overview
  4. 6.1.3 Lonza Cell Line Development CDMO Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Lonza Cell Line Development CDMO Product Portfolio
  6. 6.1.5 Lonza Recent Developments
  7. 6.2 Samsung Biologics
  8. 6.2.1 Samsung Biologics Company Information
  9. 6.2.2 Samsung Biologics Business Overview
  10. 6.2.3 Samsung Biologics Cell Line Development CDMO Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Samsung Biologics Cell Line Development CDMO Product Portfolio
  12. 6.2.5 Samsung Biologics Recent Developments
  13. 6.3 AGC Biologics
  14. 6.3.1 AGC Biologics Company Information
  15. 6.3.2 AGC Biologics Business Overview
  16. 6.3.3 AGC Biologics Cell Line Development CDMO Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 AGC Biologics Cell Line Development CDMO Product Portfolio
  18. 6.3.5 AGC Biologics Recent Developments
  19. 6.4 ProBio CDMO
  20. 6.4.1 ProBio CDMO Company Information
  21. 6.4.2 ProBio CDMO Business Overview
  22. 6.4.3 ProBio CDMO Cell Line Development CDMO Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 ProBio CDMO Cell Line Development CDMO Product Portfolio
  24. 6.4.5 ProBio CDMO Recent Developments
  25. 6.5 Creative Biolabs
  26. 6.5.1 Creative Biolabs Company Information
  27. 6.5.2 Creative Biolabs Business Overview
  28. 6.5.3 Creative Biolabs Cell Line Development CDMO Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Creative Biolabs Cell Line Development CDMO Product Portfolio
  30. 6.5.5 Creative Biolabs Recent Developments
  31. 6.6 ProBioGen
  32. 6.6.1 ProBioGen Company Information
  33. 6.6.2 ProBioGen Business Overview
  34. 6.6.3 ProBioGen Cell Line Development CDMO Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 ProBioGen Cell Line Development CDMO Product Portfolio
  36. 6.6.5 ProBioGen Recent Developments
  37. 6.7 InvivoGen
  38. 6.7.1 InvivoGen Company Information
  39. 6.7.2 InvivoGen Business Overview
  40. 6.7.3 InvivoGen Cell Line Development CDMO Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 InvivoGen Cell Line Development CDMO Product Portfolio
  42. 6.7.5 InvivoGen Recent Developments
  43. 6.8 Eurofins Discovery
  44. 6.8.1 Eurofins Discovery Company Information
  45. 6.8.2 Eurofins Discovery Business Overview
  46. 6.8.3 Eurofins Discovery Cell Line Development CDMO Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Eurofins Discovery Cell Line Development CDMO Product Portfolio
  48. 6.8.5 Eurofins Discovery Recent Developments
  49. 6.9 Innoprot
  50. 6.9.1 Innoprot Company Information
  51. 6.9.2 Innoprot Business Overview
  52. 6.9.3 Innoprot Cell Line Development CDMO Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Innoprot Cell Line Development CDMO Product Portfolio
  54. 6.9.5 Innoprot Recent Developments
  55. 6.10 AcceGen
  56. 6.10.1 AcceGen Company Information
  57. 6.10.2 AcceGen Business Overview
  58. 6.10.3 AcceGen Cell Line Development CDMO Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 AcceGen Cell Line Development CDMO Product Portfolio
  60. 6.10.5 AcceGen Recent Developments
  61. 6.11 WuXi Biologics
  62. 6.11.1 WuXi Biologics Company Information
  63. 6.11.2 WuXi Biologics Business Overview
  64. 6.11.3 WuXi Biologics Cell Line Development CDMO Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 WuXi Biologics Cell Line Development CDMO Product Portfolio
  66. 6.11.5 WuXi Biologics Recent Developments
  67. 6.12 GenScript
  68. 6.12.1 GenScript Company Information
  69. 6.12.2 GenScript Business Overview
  70. 6.12.3 GenScript Cell Line Development CDMO Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 GenScript Cell Line Development CDMO Product Portfolio
  72. 6.12.5 GenScript Recent Developments
  73. 6.13 Pharmaron
  74. 6.13.1 Pharmaron Company Information
  75. 6.13.2 Pharmaron Business Overview
  76. 6.13.3 Pharmaron Cell Line Development CDMO Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Pharmaron Cell Line Development CDMO Product Portfolio
  78. 6.13.5 Pharmaron Recent Developments
  79. 6.14 Bio-Inno
  80. 6.14.1 Bio-Inno Company Information
  81. 6.14.2 Bio-Inno Business Overview
  82. 6.14.3 Bio-Inno Cell Line Development CDMO Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Bio-Inno Cell Line Development CDMO Product Portfolio
  84. 6.14.5 Bio-Inno Recent Developments
  85. 6.15 Dingkang Biotech
  86. 6.15.1 Dingkang Biotech Company Information
  87. 6.15.2 Dingkang Biotech Business Overview
  88. 6.15.3 Dingkang Biotech Cell Line Development CDMO Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Dingkang Biotech Cell Line Development CDMO Product Portfolio
  90. 6.15.5 Dingkang Biotech Recent Developments
  91. 6.16 FUJIFILM
  92. 6.16.1 FUJIFILM Company Information
  93. 6.16.2 FUJIFILM Business Overview
  94. 6.16.3 FUJIFILM Cell Line Development CDMO Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 FUJIFILM Cell Line Development CDMO Product Portfolio
  96. 6.16.5 FUJIFILM Recent Developments
  97. 6.17 JCR Pharmaceuticals
  98. 6.17.1 JCR Pharmaceuticals Company Information
  99. 6.17.2 JCR Pharmaceuticals Business Overview
  100. 6.17.3 JCR Pharmaceuticals Cell Line Development CDMO Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 JCR Pharmaceuticals Cell Line Development CDMO Product Portfolio
  102. 6.17.5 JCR Pharmaceuticals Recent Developments
  103. 6.18 Sartorius
  104. 6.18.1 Sartorius Company Information
  105. 6.18.2 Sartorius Business Overview
  106. 6.18.3 Sartorius Cell Line Development CDMO Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Sartorius Cell Line Development CDMO Product Portfolio
  108. 6.18.5 Sartorius Recent Developments
  109. 6.19 Oxford BioMedica
  110. 6.19.1 Oxford BioMedica Company Information
  111. 6.19.2 Oxford BioMedica Business Overview
  112. 6.19.3 Oxford BioMedica Cell Line Development CDMO Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 Oxford BioMedica Cell Line Development CDMO Product Portfolio
  114. 6.19.5 Oxford BioMedica Recent Developments
  115. 6.20 Cobra Biologics
  116. 6.20.1 Cobra Biologics Company Information
  117. 6.20.2 Cobra Biologics Business Overview
  118. 6.20.3 Cobra Biologics Cell Line Development CDMO Revenue, Global Share and Gross Margin (2021-2026)
  119. 6.20.4 Cobra Biologics Cell Line Development CDMO Product Portfolio
  120. 6.20.5 Cobra Biologics Recent Developments
  121. 6.21 Evotec
  122. 6.21.1 Evotec Company Information
  123. 6.21.2 Evotec Business Overview
  124. 6.21.3 Evotec Cell Line Development CDMO Revenue, Global Share and Gross Margin (2021-2026)
  125. 6.21.4 Evotec Cell Line Development CDMO Product Portfolio
  126. 6.21.5 Evotec Recent Developments
  127. 6.22 Catalent
  128. 6.22.1 Catalent Company Information
  129. 6.22.2 Catalent Business Overview
  130. 6.22.3 Catalent Cell Line Development CDMO Revenue, Global Share and Gross Margin (2021-2026)
  131. 6.22.4 Catalent Cell Line Development CDMO Product Portfolio
  132. 6.22.5 Catalent Recent Developments
  133. 6.23 Thermo Fisher Scientific
  134. 6.23.1 Thermo Fisher Scientific Company Information
  135. 6.23.2 Thermo Fisher Scientific Business Overview
  136. 6.23.3 Thermo Fisher Scientific Cell Line Development CDMO Revenue, Global Share and Gross Margin (2021-2026)
  137. 6.23.4 Thermo Fisher Scientific Cell Line Development CDMO Product Portfolio
  138. 6.23.5 Thermo Fisher Scientific Recent Developments
  139. 6.24 Cytiva
  140. 6.24.1 Cytiva Company Information
  141. 6.24.2 Cytiva Business Overview
  142. 6.24.3 Cytiva Cell Line Development CDMO Revenue, Global Share and Gross Margin (2021-2026)
  143. 6.24.4 Cytiva Cell Line Development CDMO Product Portfolio
  144. 6.24.5 Cytiva Recent Developments
  145. 6.25 Charles River Laboratories
  146. 6.25.1 Charles River Laboratories Company Information
  147. 6.25.2 Charles River Laboratories Business Overview
  148. 6.25.3 Charles River Laboratories Cell Line Development CDMO Revenue, Global Share and Gross Margin (2021-2026)
  149. 6.25.4 Charles River Laboratories Cell Line Development CDMO Product Portfolio
  150. 6.25.5 Charles River Laboratories Recent Developments
  151. 6.26 Abzena
  152. 6.26.1 Abzena Company Information
  153. 6.26.2 Abzena Business Overview
  154. 6.26.3 Abzena Cell Line Development CDMO Revenue, Global Share and Gross Margin (2021-2026)
  155. 6.26.4 Abzena Cell Line Development CDMO Product Portfolio
  156. 6.26.5 Abzena Recent Developments
  157. 6.27 Shilpa Biologicals
  158. 6.27.1 Shilpa Biologicals Company Information
  159. 6.27.2 Shilpa Biologicals Business Overview
  160. 6.27.3 Shilpa Biologicals Cell Line Development CDMO Revenue, Global Share and Gross Margin (2021-2026)
  161. 6.27.4 Shilpa Biologicals Cell Line Development CDMO Product Portfolio
  162. 6.27.5 Shilpa Biologicals Recent Developments
  163. 6.28 Teijin
  164. 6.28.1 Teijin Company Information
  165. 6.28.2 Teijin Business Overview
  166. 6.28.3 Teijin Cell Line Development CDMO Revenue, Global Share and Gross Margin (2021-2026)
  167. 6.28.4 Teijin Cell Line Development CDMO Product Portfolio
  168. 6.28.5 Teijin Recent Developments
7 North America
  1. 7.1 North America Cell Line Development CDMO Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Cell Line Development CDMO Market Size by Country (2021-2026)
  3. 7.3 North America Cell Line Development CDMO Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Cell Line Development CDMO Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Cell Line Development CDMO Market Size by Country (2021-2026)
  3. 8.3 Europe Cell Line Development CDMO Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Cell Line Development CDMO Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Cell Line Development CDMO Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Cell Line Development CDMO Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Cell Line Development CDMO Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Cell Line Development CDMO Market Size by Country (2021-2026)
  3. 10.3 South America Cell Line Development CDMO Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Cell Line Development CDMO Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Cell Line Development CDMO Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Cell Line Development CDMO Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst